TY - JOUR
T1 - Use of wearable activity tracker in patients wi cancer undergoing chemotherapy
T2 - Toward evaluating risk of unplanned health care encounters
AU - Nilanon, Tanachat
AU - Nocera, Luciano P.
AU - Martin, Alexander S.
AU - Kolatkar, Anand
AU - May, Marcella
AU - Hasnain, Zaki
AU - Ueno, Naoto T.
AU - Yennu, Sriram
AU - Alexander, Angela
AU - Mejia, Aaron E.
AU - Boles, Roger Wilson
AU - Li, Ming
AU - Lee, Jerry S.H.
AU - Hanlon, Sean E.
AU - Cozzens Philips, Frankie A.
AU - Quinn, David I.
AU - Newton, Paul K.
AU - Broderick, Joan
AU - Shahabi, Cyrus
AU - Kuhn, Peter
AU - Nieva, Jorge J.
N1 - Publisher Copyright:
© 2020 by American Society of Clinical Oncology.
PY - 2020
Y1 - 2020
N2 - PURPOSE Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Eastern Cooperative Oncology Group (ECOG) scale. Such assessments can be bias prone, resulting in PS score disagreements between assessors. We therefore propose to evaluate PS using physical activity measurements (eg, energy expenditure) from wearable activity trackers. Specifically, we examined the feasibility of using a wristband (band) and a smartphone app for PS assessments. METHODS We conducted an observational study on a cohort of patients with solid tumor receiving highly emetogenic chemotherapy. Patients were instructed to wear the band for a 60-day activity-tracking period. During clinic visits, we obtained ECOG scores assessed by physicians, coordinators, and patients themselves. UHEs occurring during the activity-tracking period plus a 90-day follow-up period were later compiled. We defined our primary outcome as the percentage of patients adherent to band-wear ≥ 80% of 10 AM to 8 PM for ≥ 80% of the activity-tracking period. In an exploratory analysis, we computed hourly metabolic equivalent of task (MET) and counted 10 AM to 8 PM hours with . 1.5 METs as nonsedentary physical activity hours. RESULTS Forty-one patients completed the study (56.1% female; 61.0% age 40-60 years); 68% were adherent to band-wear. ECOG score disagreement between assessors ranged from 35.3% to 50.0%. In our exploratory analysis, lower average METs and nonsedentary hours, but not higher ECOG scores, were associated with higher 150-day UHEs. CONCLUSION The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs.
AB - PURPOSE Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Eastern Cooperative Oncology Group (ECOG) scale. Such assessments can be bias prone, resulting in PS score disagreements between assessors. We therefore propose to evaluate PS using physical activity measurements (eg, energy expenditure) from wearable activity trackers. Specifically, we examined the feasibility of using a wristband (band) and a smartphone app for PS assessments. METHODS We conducted an observational study on a cohort of patients with solid tumor receiving highly emetogenic chemotherapy. Patients were instructed to wear the band for a 60-day activity-tracking period. During clinic visits, we obtained ECOG scores assessed by physicians, coordinators, and patients themselves. UHEs occurring during the activity-tracking period plus a 90-day follow-up period were later compiled. We defined our primary outcome as the percentage of patients adherent to band-wear ≥ 80% of 10 AM to 8 PM for ≥ 80% of the activity-tracking period. In an exploratory analysis, we computed hourly metabolic equivalent of task (MET) and counted 10 AM to 8 PM hours with . 1.5 METs as nonsedentary physical activity hours. RESULTS Forty-one patients completed the study (56.1% female; 61.0% age 40-60 years); 68% were adherent to band-wear. ECOG score disagreement between assessors ranged from 35.3% to 50.0%. In our exploratory analysis, lower average METs and nonsedentary hours, but not higher ECOG scores, were associated with higher 150-day UHEs. CONCLUSION The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs.
UR - http://www.scopus.com/inward/record.url?scp=85091618388&partnerID=8YFLogxK
U2 - 10.1200/CCI.20.00023
DO - 10.1200/CCI.20.00023
M3 - Article
C2 - 32970482
AN - SCOPUS:85091618388
SN - 2473-4276
VL - 4
SP - 839
EP - 853
JO - JCO Clinical Cancer Informatics
JF - JCO Clinical Cancer Informatics
ER -